Literature DB >> 2297582

The origin of the membrane convolute in degranulating platelets. A comparative study of normal and "gray" platelets.

E Morgenstern1, H Patscheke, G Mathieu.   

Abstract

Thrombin-stimulated normal platelets contain a membrane system of dilated channels with openings to the exterior. Whether these membranes originate from the surface connected system (SCS), the alpha-granules or internalized portions of the plasmalemma has not yet been defined. The present study traces in series of ultrathin sections the rearrangement of these membranes during shape change, degranulation and internalization of surface membranes in washed normal and "gray" platelets upon the stimulation with thrombin (1 IU/ml). Cationized ferritin (CF) was used as a surface marker in order to recognize internalized portions of the plasmalemma. Within the first seconds after stimulation, both normal and gray platelets changed their shape by extrusion of the SCS membranes. Simultaneously they started to internalize surface membrane and formed surface membrane invaginations closely attached to the outer rim of the cytoskeletal sphere which developed during the internal contraction. CF was internalized in these invaginations. CF was not observed within the system of dilated channels of stimulated platelets, however. Thrombin-stimulated gray platelets showed a markedly reduced number of dilated channels or none at all. This observation may be due to the fact "gray" platelets are deficient in alpha-granules. It is concluded that the dilated system of membranes in degranulated normal platelets originates from membranes of the alpha-granules which have performed compound exocytosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297582     DOI: 10.1007/bf01720197

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  25 in total

1.  Receptor patching and capping of platelet membranes induced by monoclonal antibodies.

Authors:  S Santoso; U Zimmermann; J Neppert; C Mueller-Eckhardt
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

2.  Rearrangement of the open-canalicular system of the human blood platelet after incorporation of surface-bound ligands. A high-voltage electron-microscopic study.

Authors:  H Kawakami; H Hirano
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  Gray platelet syndrome. A variety of qualitative platelet disorder.

Authors:  G Raccuglia
Journal:  Am J Med       Date:  1971-12       Impact factor: 4.965

4.  The platelet contacts during aggregation.

Authors:  E Morgenstern; H J Reimers
Journal:  Blut       Date:  1984-02

Review 5.  Human platelet size, shape, and related functions in health and disease.

Authors:  M M Frojmovic; J G Milton
Journal:  Physiol Rev       Date:  1982-01       Impact factor: 37.312

6.  The exocytosis of human blood platelets. A fast freezing and freeze-substitution analysis.

Authors:  E Morgenstern; K Neumann; H Patscheke
Journal:  Eur J Cell Biol       Date:  1987-04       Impact factor: 4.492

7.  Electron microscopic observations on platelet aggregation induced by cationized ferritin.

Authors:  H Yamazaki; H Suzuki; N Yamamoto; K Tanoue
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

8.  Shape and functional properties of human platelets washed with acid citrate.

Authors:  H Patscheke
Journal:  Haemostasis       Date:  1981

9.  Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function.

Authors:  S Levy-Toledano; J P Caen; J Breton-Gorius; F Rendu; C Cywiner-Golenzer; E Dupuy; Y Legrand; J Maclouf
Journal:  J Lab Clin Med       Date:  1981-12

10.  A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation.

Authors:  P E Stenberg; R P McEver; M A Shuman; Y V Jacques; D F Bainton
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

View more
  1 in total

1.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.